ADAM10 expression and promoter haplotype in Alzheimer's disease

Neurobiology of Aging

Volumn 33, Issue 9, 2012, Pages 2229.e1-2229.e9

  Bekris, Lynn M ^a,b   Lutz, Franziska ^a,b   Li, Gail ^c   Galasko, Douglas R ^d   Farlow, Martin R ^e   Quinn, Joseph F ^f,g   Kaye, Jeffrey A ^f,g   Leverenz, James B ^a,c,h   Tsuang, Debby W ^a,c   Montine, Thomas J ^b   Peskind, Elaine R ^a,c   Yu, Chang En ^a,b  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^g PORTLAND VA MEDICAL CENTER   (United States)

^h Northwest Network VISN 20 Parkinson's Disease Research Education and Clinical Center (PADRECC)   (United States)

Author keywords

ADAM10; Alzheimer's disease; Brain; Cerebrospinal fluid; Haplotype; Hippocampus; Neuritic plaques; Reporter assay; SAPP

Indexed keywords

ADAM10 ENDOPEPTIDASE; AMYLOID PRECURSOR PROTEIN; BRAIN PROTEIN; SOLUBLE AMYLOID PRECURSOR PROTEIN ALPHA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADAM10 GENE; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN LEVEL; BRAIN REGION; CELL SPECIFICITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA CELL; NEUROMODULATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; TISSUE SPECIFICITY;

EID: 84863449066     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.03.013     Document Type: Article

References (32)

1. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. [PubMed: 15297300]. 10.1093/bioinformatics/bth457.
2. Bekris L.M., Galloway N.M., Millard S., Lockhart D., Li G., Galasko D.R., Farlow M.R., Clark C.M., Quinn J.F., Kaye J.A., Schellenberg G.D., Leverenz J.B., Seubert P., Tsuang D.W., Peskind E.R., Yu C.E. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiol. Aging 2011, 32:e13-e23.
3. Bekris L.M., Millard S.P., Galloway N.M., Vuletic S., Albers J.J., Li G., Galasko D.R., DeCarli C., Farlow M.R., Clark C.M., Quinn J.F., Kaye J.A., Schellenberg G.D., Tsuang D., Peskind E.R., Yu C.E. Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels. J. Alzheimers Dis. 2008, 13:255-266. [PubMed: 18430993].
4. Bernstein H.G., Stricker R., Lendeckel U., Bertram I., Dobrowolny H., Steiner J., Bogerts B., Reiser G. Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains. Age (Dordr) 2009, 31:11-25.
5. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259. [PubMed: 1759558]. 10.1007/BF00308809.
6. Cai G., Atzmon G., Naj A.C., Beecham G.W., Barzilai N., Haines J.L., Sano M., Pericak-Vance M., Buxbaum J.D. Evidence against a role for rare ADAM10 mutations in sporadic Alzheimer disease. Neurobiol. Aging 2012, 33:416-417. [http://dx.doi.org/10.1016/j.neurobiolaging.2010.03.003] [PubMed: 20381196] e3.
7. Colciaghi F., Borroni B., Pastorino L., Marcello E., Zimmermann M., Cattabeni F., Padovani A., Di Luca M. α-Secretase ADAM10 as well as αAPPs is reduced in platelets and CSF of Alzheimer disease patients. Mol. Med. 2002, 8:67-74. [PubMed: 12080182].
8. Colciaghi F., Marcello E., Borroni B., Zimmermann M., Caltagirone C., Cattabeni F., Padovani A., Di Luca M. Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology 2004, 62:498-501. [PubMed: 14872043].
9. Endres K., Postina R., Schroeder A., Mueller U., Fahrenholz F. Shedding of the amyloid precursor protein-like protein APLP2 by disintegrin-metalloproteinases. FEBS J. 2005, 272:5808-5820. [PubMed: 16279945]. 10.1111/j.1742-4658.2005.04976.x.
10. Fahrenholz F., Gilbert S., Kojro E., Lammich S., Postina R. Alpha-secretase activity of the disintegrin metalloprotease ADAM 10. Influences of domain structure. Ann. N. Y. Acad. Sci. 2000, 920:215-222. [PubMed: 11193153].
11. Gatta L.B., Albertini A., Ravid R., Finazzi D. Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus. Neuroreport 2002, 13:2031-2033. [PubMed: 12438920]. 10.1097/00001756-200211150-00008.
12. Jack C.R., Vemuri P., Wiste H.J., Weigand S.D., Aisen P.S., Trojanowski J.Q., Shaw L.M., Bernstein M.A., Petersen R.C., Weiner M.W., Knopman D.S. Evidence for ordering of Alzheimer disease biomarkers. Arch. Neurol. 2011, 68:1526-1535. [PubMed: 21825215]. 10.1001/archneurol.2011.183.
13. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P., McConlogue L. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1550-1555. [PubMed: 9037091]. 10.1073/pnas.94.4.1550.
14. Kim M., Suh J., Romano D., Truong M.H., Mullin K., Hooli B., Norton D., Tesco G., Elliott K., Wagner S.L., Moir R.D., Becker K.D., Tanzi R.E. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum. Mol. Genet. 2009, 18:3987-3996. [PubMed: 19608551]. 10.1093/hmg/ddp323.
15. Kojro E., Gimpl G., Lammich S., Marz W., Fahrenholz F. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5815-5820. [PubMed: 11309494]. 10.1073/pnas.081612998.
16. Lammich S., Buell D., Zilow S., Ludwig A.K., Nuscher B., Lichtenthaler S.F., Prinzen C., Fahrenholz F., Haass C. Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region. J. Biol. Chem. 2010, 285:15753-15760. [PubMed: 20348102]. 10.1074/jbc.M110.110742.
17. Laws S.M., Eckart K., Friedrich P., Kurz A., Förstl H., Riemenschneider M. Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease. Neurobiol. Aging 2011, 32:541-543. [http://dx.doi.org/10.1016/j.neurobiolaging.2009.02.023] [PubMed: 19344981].
18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944. [PubMed: 6610841].
19. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486. [PubMed: 2011243].
20. Peskind E.R., Li G., Shofer J., Quinn J.F., Kaye J.A., Clark C.M., Farlow M.R., DeCarli C., Raskind M.A., Schellenberg G.D., Lee V.M., Galasko D.R. Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch. Neurol. 2006, 63:936-939. [PubMed: 16831961]. 10.1001/archneur.63.7.936.
21. Peskind E.R., Riekse R., Quinn J.F., Kaye J., Clark C.M., Farlow M.R., Decarli C., Chabal C., Vavrek D., Raskind M.A., Galasko D. Safety and acceptability of the research lumbar puncture. Alzheimer Dis. Assoc. Disord. 2005, 19:220-225. [PubMed: 16327349]. 10.1097/01.wad.0000194014.43575.fd.
22. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308. [PubMed: 10190820]. 10.1001/archneur.56.3.303.
23. Postina R. A closer look at alpha-secretase. Curr. Alzheimer Res. 2008, 5:179-186. [PubMed: 18393803]. 10.2174/156720508783954668.
24. Postina R. Activation of alpha-secretase cleavage. J. Neurochem. 2012 Jan, (120 Suppl 1):46-54.
25. Postina R., Schroeder A., Dewachter I., Bohl J., Schmitt U., Kojro E., Prinzen C., Endres K., Hiemke C., Blessing M., Flamez P., Dequenne A., Godaux E., van Leuven F., Fahrenholz F. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 2004, 113:1456-1464. [PubMed: 15146243]. 10.1172/JCI200420864.
26. Prinzen C., Müller U., Endres K., Fahrenholz F., Postina R. Genomic structure and functional characterization of the human ADAM10 promoter. FASEB J. 2005, 19:1522-1524. [PubMed: 15972296].
27. Rosenbloom K.R., Dreszer T.R., Long J.C., Malladi V.S., Sloan C.A., Raney B.J., Cline M.S., Karolchik D., Barber G.P., Clawson H., Diekhans M., Fujita P.A., Goldman M., Gravell R.C., Harte R.A., Hinrichs A.S., Kirkup V.M., Kuhn R.M., Learned K., Maddren M., Meyer L.R., Pohl A., Rhead B., Wong M.C., Zweig A.S., Haussler D., Kent W.J. ENCODE whole-genome data in the UCSC Genome Browser: update 2012. Nucleic Acids Res. 2012, 40:D912-D917.
28. Selkoe D.J. The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 1998, 8:447-453. [PubMed: 9854312]. 10.1016/S0962-8924(98)01363-4.
29. Siegel G., Saba R., Schratt G. microRNAs in neurons: manifold regulatory roles at the synapse. Curr. Opin. Genet. Dev. 2011, 21:491-497. [http://dx.doi.org/10.1016/j.gde.2011.04.008] [PubMed: 21561760].
30. Steele M.L., Robinson S.R. Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol. Aging 2012, 33:e1-e13.
31. Tang K., Hynan L.S., Baskin F., Rosenberg R.N. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J. Neurol. Sci. 2006, 240:53-58. [http://dx.doi.org/10.1016/j.jns.2005.09.002] [PubMed: 16256140].
32. Tippmann F., Hundt J., Schneider A., Endres K., Fahrenholz F. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. FASEB J. 2009, 23:1643-1654. [PubMed: 19144697]. 10.1096/fj.08-121392.